Klingman & Associates’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Sell |
12,164
-225
| -2% | -$25.4K | 0.06% | 115 |
|
|
2025
Q4 | $1.55M | Buy |
12,389
+105
| +0.9% | +$13.4K | 0.07% | 100 |
|
|
2025
Q3 | $1.65M | Sell |
12,284
-206
| -2% | -$27K | 0.08% | 93 |
|
|
2025
Q2 | $1.7M | Buy |
12,490
+1,876
| +18% | +$247K | 0.09% | 87 |
|
|
2025
Q1 | $1.41M | Buy |
10,614
+513
| +5% | +$65.3K | 0.09% | 89 |
|
|
2024
Q4 | $1.14M | Sell |
10,101
-1,290
| -11% | -$149K | 0.07% | 95 |
|
|
2024
Q3 | $1.3M | Buy |
11,391
+3,689
| +48% | +$405K | 0.08% | 96 |
|
|
2024
Q2 | $800K | Buy |
7,702
+508
| +7% | +$53.9K | 0.05% | 107 |
|
|
2024
Q1 | $818K | Sell |
7,194
-37
| -0.5% | -$4.24K | 0.06% | 111 |
|
|
2023
Q4 | $796K | Sell |
7,231
-475
| -6% | -$47.5K | 0.06% | 106 |
|
|
2023
Q3 | $746K | Sell |
7,706
-231
| -3% | -$24.3K | 0.06% | 107 |
|
|
2023
Q2 | $865K | Sell |
7,937
-239
| -3% | -$25.5K | 0.07% | 96 |
|
|
2023
Q1 | $828K | Sell |
8,176
-127
| -2% | -$13.4K | 0.07% | 89 |
|
|
2022
Q4 | $912K | Sell |
8,303
-1,274
| -13% | -$132K | 0.08% | 85 |
|
|
2022
Q3 | $927K | Buy |
9,577
+136
| +1% | +$14.5K | 0.09% | 79 |
|
|
2022
Q2 | $1.03M | Buy |
9,441
+46
| +0.5% | +$5.22K | 0.1% | 72 |
|
|
2022
Q1 | $1.11M | Buy |
9,395
+3,595
| +62% | +$446K | 0.09% | 71 |
|
|
2021
Q4 | $816K | Buy |
5,800
+52
| +0.9% | +$6.66K | 0.07% | 80 |
|
|
2021
Q3 | $679K | Buy |
5,748
+1,571
| +38% | +$193K | 0.06% | 88 |
|
|
2021
Q2 | $484K | Sell |
4,177
-648
| -13% | -$75.5K | 0.05% | 98 |
|
|
2021
Q1 | $578K | Buy |
4,825
+683
| +16% | +$80.9K | 0.06% | 88 |
|
|
2020
Q4 | $454K | Buy |
4,142
+216
| +6% | +$23.5K | 0.05% | 97 |
|
|
2020
Q3 | $427K | Buy |
3,926
+1,643
| +72% | +$167K | 0.06% | 89 |
|
|
2020
Q2 | $209K | Buy |
+2,283
| New | +$206K | 0.03% | 121 |
|
|
2020
Q1 | – | Sell |
-2,536
| Closed | -$220K | – | 121 |
|
|
2019
Q4 | $220K | Buy |
+2,536
| New | +$212K | 0.04% | 128 |
|
|
2016
Q4 | – | Sell |
-2,056
| Closed | -$87K | – | 98 |
|
|
2016
Q3 | $87K | Sell |
2,056
-650
| -24% | -$27.9K | 0.03% | 147 |
|
|
2016
Q2 | $106K | Hold |
2,706
| – | – | 0.03% | 135 |
|
|
2016
Q1 | $113K | Hold |
2,706
| – | – | 0.04% | 127 |
|
|
2015
Q4 | $122K | Hold |
2,706
| – | – | 0.05% | 140 |
|
|
2015
Q3 | $108K | Hold |
2,706
| – | – | 0.04% | 149 |
|
|
2015
Q2 | $133K | Buy |
2,706
+94
| +4% | +$4.51K | 0.05% | 106 |
|
|
2015
Q1 | $121K | Hold |
2,612
| – | – | 0.05% | 113 |
|
|
2014
Q4 | $117K | Buy |
+2,612
| New | +$114K | 0.05% | 112 |
|
Other funds holding ABT
VCM
VPM
Klingman & Associates's ABT Position: Q1 2026 in Review
Klingman & Associates reduced its Abbott (ABT) stake by 1.8% in Q1 2026, selling an estimated $25.4K and leaving 12,164 shares worth $1.25M. The position accounts for 0.06% of the portfolio, ranked #115.
Klingman & Associates first reported a position in ABT in Q4 2014 and has held it in 33 quarters since. The position peaked at $1.7M in Q2 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.
- Klingman & Associates held 12,164 shares of Abbott worth $1.25M as of Q1 2026.
- Klingman & Associates sold 225 Abbott shares in Q1 2026, an estimated $25.4K.
- Abbott made up 0.06% of Klingman & Associates's portfolio in Q1 2026, its #115 holding.
- Klingman & Associates first reported a position in Abbott in Q4 2014 and has held it in 33 quarters since.
- Klingman & Associates's Abbott position peaked at $1.7M in Q2 2025.
- 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.
Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.